Please use this identifier to cite or link to this item: https://doi.org/10.1080/10428194.2017.1298755
Title: Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup
Authors: Heinz Ludwig
Meletios A. Dimopoulos
Philippe Moreau
Wee Joo Chng 
Hartmut Goldschmidt
Roman Hajek
Thierry Facon
Ludek Pour
Ruben Niesvizky
Albert Oriol
Laura Rosinol
Aleksandr Suvorov
Gianluca Gaidano
Tomas Pika
Katja Weisel
Vesselina Goranova-Marinova
Antonio Palumbo
Heidi Gillenwater
Nehal Mohamed
Sanjay Aggarwal
Shibao Feng
Douglas Joshua
Issue Date: 17-Mar-2017
Publisher: Taylor & Francis
Citation: Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee Joo Chng, Hartmut Goldschmidt, Roman Hajek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosinol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng, Douglas Joshua (2017-03-17). Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup. Leukemia & Lymphoma 58 (10) : 2501-2504. ScholarBank@NUS Repository. https://doi.org/10.1080/10428194.2017.1298755
Source Title: Leukemia & Lymphoma
URI: http://scholarbank.nus.edu.sg/handle/10635/141100
ISSN: 1042-8194
DOI: 10.1080/10428194.2017.1298755
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108010428194.2017.1298755.zip467.36 kBZIP

OPEN

NoneView/Download

SCOPUSTM   
Citations

6
checked on Sep 23, 2018

Page view(s)

9
checked on Sep 20, 2018

Download(s)

1
checked on Sep 20, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.